N/A
Completed N=150
Postoperative Pain Control Following Hysteroscopy
Postoperative Pain · Postoperative Nausea · Analgesia
Source: ClinicalTrials.gov NCT06423456 ↗
Enrolled (actual)
150
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcomePrimary: Visual Analog Scale (VAS) — 2.49; 4.44; 1.23; 2.40 score on a scale
Summary
Intraoperative lidocaine infusion is a frequently preferred method in surgical procedures due to its reducing the need for opioids, providing better postoperative pain control, reducing postoperative nausea and vomiting and increasing rapid recovery. Our aim in this study is to show the effect of intraoperative lidocaine infusion on reducing complications such as pain, nausea, vomiting, and the need for opioid analgesia that occur after hysteroscopy operations, which are often performed in gynecology clinics.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Visual Analog Scale (VAS) |
2.49; 4.44; 1.23; 2.40; 0.61; 1.09 | — |
Eligibility Criteria
Inclusion Criteria
- Female patients with ASA I-II according to the American Society of Anesthesiologists (ASA) classification who are scheduled for elective hysteroscopy with indications such as
- abnormal uterine bleeding
- endometrial polyp
- submucosal myoma
- foreign body in the endometrial cavity
- infertility
- intrauterine synechia
Exclusion Criteria
- Patients under the age of 18
- Who are allergic to lidocaine addicted to opioids or NSAIDs
- Patients with chronic pain
- Patients with severe systemic disease
- Patients who do not approve
Data sourced from ClinicalTrials.gov (NCT06423456). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.